Markets are trading on an optimistic note as all the major indices are in green zone. The major push for the markets comes from Hillary Clinton being...
Keep Reading →
October 10 - Market Movers, News - Comments
While crude prices are now at a monthly high and the S&P 500 is above 2,100, some stocks have been left behind. Among the stocks deep in the red today...
Keep Reading →
April 19 - Market Movers, News - Comments
According to its latest 13G filing with the U.S. Securities and Exchange Commission, Chuck Royce’s Royce & Associates reduced its exposure to Meredith...
Keep Reading →
January 20 - Hedge Funds, News - Comments
Consonance Capital Management is a New York based hedge fund established in 2005, managed by Mitchell Blutt MD. The firm usually invests in the lower...
Keep Reading →
May 27 - Hedge Funds, News - Comments
What’s a smart Qiagen NV (NASDAQ:QGEN) investor to do? To many market players, hedge funds are viewed as delayed, old investment vehicles of a...
Keep Reading →
September 17 - News - Comments
In the 21st century investor’s toolkit, there are plenty of gauges shareholders can use to track the equity markets. Some of the best are hedge fund...
Keep Reading →
August 28 - News - Comments
On a day-to-day basis, there are countless analyst calls – some of which are good and others that are bad – and in this piece, I am looking at three...
Keep Reading →
June 28 - News - Comments
Qiagen NV (NASDAQ:QGEN) shareholders have witnessed an increase in activity from the world’s largest hedge funds recently. According to most shareholders...
Keep Reading →
June 19 - News - Comments
It’s not easy being a biotech company. Every year, the biotech industry pours billions of dollars in research and development costs towards creating...
Keep Reading →
June 18 - News - Comments
Although we don’t believe in timing the market or panicking over market movements, we do like to keep an eye on big changes — just in case...
Keep Reading →
June 14 - News - Comments
Forrester Research, Inc. (NASDAQ:FORR) was in 11 hedge funds’ portfolio at the end of March. FORR has seen a decrease in hedge fund interest lately...
Keep Reading →
June 10 - News - Comments
Can we patent human genomes? This sounds so academic, except that the future of at least one biotech company hinges on an answer to this question. On...
Keep Reading →
June 5 - News - Comments
Myriad Genetics, Inc. (NASDAQ:MYGN) was in 19 hedge funds’ portfolio at the end of March. MYGN has experienced a decrease in enthusiasm from smart...
Keep Reading →
May 30 - News - Comments
I admit to not being a big fan of many of her movies — possibly the only man on the planet who will admit so — but there’s little denying...
Keep Reading →
May 16 - News - Comments
Sony Corporation (ADR) (NYSE:SNE) – Big prints in Sony Corporation (ADR) (NYSE:SNE) call and put options this morning pushed the consumer electronics...
Keep Reading →
May 14 - News - Comments
Sony Corporation (ADR) (NYSE:SNE) – Big prints in Sony Corporation (ADR) (NYSE:SNE) call and put options this morning pushed the consumer electronics...
Keep Reading →
May 13 - News - Comments
Editor’s Note: Related tickers: Theravance Inc (NASDAQ:THRX), VIVUS, Inc. (NASDAQ:VVUS), Amgen, Inc. (NASDAQ:AMGN), Acorda Therapeutics Inc (NASDAQ...
Keep Reading →
April 15 - News - Comments
Monday was a somewhat slow day in terms of companies reporting earnings; however like all days during earnings season, opportunity still presented itself...
Keep Reading →
March 5 - News - Comments
The market has been less than thrilled about an upcoming Supreme Court decision on the legality of the best-selling analytical test of Myriad Genetics...
Keep Reading →
March 5 - News - Comments
